Laboratory Corp. (LH) Tops Q2 EPS by 7c; Boosts FY14 EPS Outlook
Tweet
Share
E-mailGet Alerts LH Hot Sheet
Price: $326.89 -1.39%
EPS Growth %: +11.2%
Financial Fact:
Other, net: -5.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +11.2%
Financial Fact:
Other, net: -5.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.84, $0.07 better than the analyst estimate of $1.77. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.5 billion.
Laboratory Corp. sees FY2014 EPS of $6.50 - $6.75, versus prior guidance of $6.40 - $6.70 and the consensus of $6.68.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
- BlackRock’s Rosenberg says inflation data key after jobs beat
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
